TD Asset Management »

Apellis Pharmaceuticals shares owned by TD Asset Management

Quarter-by-quarter ownership of Apellis Pharmaceuticals (APLS) shares owned by TD Asset Management from 13F filings

Historical chart of TD Asset Management investment in Apellis Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Apellis Pharmaceuticals held by TD Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Apellis Pharmaceuticals by TD Asset Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $29M 483k 59.86
2023-09-30 $14M 371k 38.04
2023-06-30 $44M 479k 91.10
2023-03-31 $25M 378k 65.96
2022-12-31 $14M 272k 51.71
2022-09-30 $18M 279k 65.41
2022-06-30 $13M 279k 45.22
2022-03-31 $13M 248k 50.81
2021-12-31 $7.6M 161k 47.28
2021-09-30 $3.9M 120k 32.96
2021-06-30 $8.9M 139k 63.99
2021-03-31 $4.4M 103k 42.91
2020-12-31 $4.4M 76k 57.21
2020-09-30 $2.0M 67k 30.18
2020-06-30 $2.2M 67k 32.66
2020-03-31 $837k 31k 26.79
2019-12-31 $697k 23k 30.62
2019-09-30 $548k 23k 24.07
2019-06-30 $429k 17k 25.32
2019-03-31 $330k 17k 19.48
2018-12-31 $262k 20k 13.20
2018-09-30 $346k 19k 17.80
2018-06-30 $428k 19k 22.02